These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 14729074)

  • 1. Low density lipoprotein induces eNOS translocation to membrane caveolae: the role of RhoA activation and stress fiber formation.
    Zhu Y; Liao HL; Niu XL; Yuan Y; Lin T; Verna L; Stemerman MB
    Biochim Biophys Acta; 2003 Dec; 1635(2-3):117-26. PubMed ID: 14729074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Native low-density lipoprotein induces endothelial nitric oxide synthase dysfunction: role of heat shock protein 90 and caveolin-1.
    Pritchard KA; Ackerman AW; Ou J; Curtis M; Smalley DM; Fontana JT; Stemerman MB; Sessa WC
    Free Radic Biol Med; 2002 Jul; 33(1):52-62. PubMed ID: 12086682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hydroxy-methylglutaryl-coenzyme A reductase inhibition promotes endothelial nitric oxide synthase activation through a decrease in caveolin abundance.
    Feron O; Dessy C; Desager JP; Balligand JL
    Circulation; 2001 Jan; 103(1):113-8. PubMed ID: 11136695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypercholesterolemia decreases nitric oxide production by promoting the interaction of caveolin and endothelial nitric oxide synthase.
    Feron O; Dessy C; Moniotte S; Desager JP; Balligand JL
    J Clin Invest; 1999 Mar; 103(6):897-905. PubMed ID: 10079111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Opposing effects of reactive oxygen species and cholesterol on endothelial nitric oxide synthase and endothelial cell caveolae.
    Peterson TE; Poppa V; Ueba H; Wu A; Yan C; Berk BC
    Circ Res; 1999 Jul; 85(1):29-37. PubMed ID: 10400908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Caveolin-1 expression is critical for vascular endothelial growth factor-induced ischemic hindlimb collateralization and nitric oxide-mediated angiogenesis.
    Sonveaux P; Martinive P; DeWever J; Batova Z; Daneau G; Pelat M; Ghisdal P; Grégoire V; Dessy C; Balligand JL; Feron O
    Circ Res; 2004 Jul; 95(2):154-61. PubMed ID: 15205364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High density lipoprotein prevents oxidized low density lipoprotein-induced inhibition of endothelial nitric-oxide synthase localization and activation in caveolae.
    Uittenbogaard A; Shaul PW; Yuhanna IS; Blair A; Smart EJ
    J Biol Chem; 2000 Apr; 275(15):11278-83. PubMed ID: 10753938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxidized low density lipoprotein displaces endothelial nitric-oxide synthase (eNOS) from plasmalemmal caveolae and impairs eNOS activation.
    Blair A; Shaul PW; Yuhanna IS; Conrad PA; Smart EJ
    J Biol Chem; 1999 Nov; 274(45):32512-9. PubMed ID: 10542298
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclosporin A inhibits flow-mediated activation of endothelial nitric-oxide synthase by altering cholesterol content in caveolae.
    Lungu AO; Jin ZG; Yamawaki H; Tanimoto T; Wong C; Berk BC
    J Biol Chem; 2004 Nov; 279(47):48794-800. PubMed ID: 15383526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PKC is required for activation of ROCK by RhoA in human endothelial cells.
    Barandier C; Ming XF; Rusconi S; Yang Z
    Biochem Biophys Res Commun; 2003 May; 304(4):714-9. PubMed ID: 12727213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardioprotective mechanisms of Rho-kinase inhibition associated with eNOS and oxidative stress-LOX-1 pathway in Dahl salt-sensitive hypertensive rats.
    Mita S; Kobayashi N; Yoshida K; Nakano S; Matsuoka H
    J Hypertens; 2005 Jan; 23(1):87-96. PubMed ID: 15643129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RhoA/Rho-kinase suppresses endothelial nitric oxide synthase in the penis: a mechanism for diabetes-associated erectile dysfunction.
    Bivalacqua TJ; Champion HC; Usta MF; Cellek S; Chitaley K; Webb RC; Lewis RL; Mills TM; Hellstrom WJ; Kadowitz PJ
    Proc Natl Acad Sci U S A; 2004 Jun; 101(24):9121-6. PubMed ID: 15184671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thrombin stimulates human endothelial arginase enzymatic activity via RhoA/ROCK pathway: implications for atherosclerotic endothelial dysfunction.
    Ming XF; Barandier C; Viswambharan H; Kwak BR; Mach F; Mazzolai L; Hayoz D; Ruffieux J; Rusconi S; Montani JP; Yang Z
    Circulation; 2004 Dec; 110(24):3708-14. PubMed ID: 15569838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reconstituted high-density lipoprotein inhibits thrombin-induced endothelial tissue factor expression through inhibition of RhoA and stimulation of phosphatidylinositol 3-kinase but not Akt/endothelial nitric oxide synthase.
    Viswambharan H; Ming XF; Zhu S; Hubsch A; Lerch P; Vergères G; Rusconi S; Yang Z
    Circ Res; 2004 Apr; 94(7):918-25. PubMed ID: 14988229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nitric oxide attenuates signal transduction: possible role in dissociating caveolin-1 scaffold.
    Li H; Brodsky S; Basco M; Romanov V; De Angelis DA; Goligorsky MS
    Circ Res; 2001 Feb; 88(2):229-36. PubMed ID: 11157677
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The endothelial nitric-oxide synthase-caveolin regulatory cycle.
    Feron O; Saldana F; Michel JB; Michel T
    J Biol Chem; 1998 Feb; 273(6):3125-8. PubMed ID: 9452418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypochlorite-modified low density lipoprotein inhibits nitric oxide synthesis in endothelial cells via an intracellular dislocalization of endothelial nitric-oxide synthase.
    Nuszkowski A; Gräbner R; Marsche G; Unbehaun A; Malle E; Heller R
    J Biol Chem; 2001 Apr; 276(17):14212-21. PubMed ID: 11278358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rho-kinase activation contributes to Lps-induced impairment of endothelial nitric oxide synthase activation by endothelin-1 in cultured hepatic sinusoidal endothelial cells.
    Kwok W; Clemens MG
    Shock; 2014 Dec; 42(6):554-61. PubMed ID: 25243430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rho-kinase mediates hypoxia-induced downregulation of endothelial nitric oxide synthase.
    Takemoto M; Sun J; Hiroki J; Shimokawa H; Liao JK
    Circulation; 2002 Jul; 106(1):57-62. PubMed ID: 12093770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Citron Rho-interacting kinase mediates arsenite-induced decrease in endothelial nitric oxide synthase activity by increasing phosphorylation at threonine 497: Mechanism underlying arsenite-induced vascular dysfunction.
    Seo J; Cho DH; Lee HJ; Sung MS; Lee JY; Won KJ; Park JH; Jo I
    Free Radic Biol Med; 2016 Jan; 90():133-44. PubMed ID: 26593676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.